The customer reported false elevated architect calcium results for one patient.The initial information from the customer provided: (b)(6) initial = 3.00 mmol/l, repeat = 2.21 mmol/l (reference range 2.10 to 2.55 mmol/l).On (b)(6) 2020 the customer provided additional results for of (b)(6), which ranged from 2.06 mmol/l to 4.40 mmol/l.There was no reported impact to patient management.
|
The evaluation of the customer¿s issue included a search for similar complaints, trending data, device history records, labeling and historical performance of reagent lot review 38264un20.A review of tickets determined that there is normal complaint activity for lot number 38264un20.Trending review of list number 3l79 determined no trend for erratic patient results due to the product.Return testing was not completed as returns were not available.Transferring the sample to a sample cup produced acceptable result.A review of the manufacturing documentation did not identify any issues associated with the customer's observation.A review of the product labeling concluded that the issue is sufficiently addressed.Based on the investigation, no systemic issue or deficiency of architect calcium reagent (ln 3l79-32) lot number 38264un20 was identified.A review of tracking and trending data did not identify an increase in complaint activity related to the current complaint issue.Based on all available information no systemic issue or product deficiency was identified.D4 - catalog no: changed from 03l79-22 to 03l79-32 d4 - unique identifier (udi) #: changed from 00380740161491 to 00380740161507 d4 - lot no: changed from unknown to 3826un20.
|